Skip to main content
LH logo

LH · Labcorp Holdings Inc. · Webcasts, Transcripts & Audio

Track LH — free
Market Cap
$29.90B
Shares
81.20M
Volume · Nov 18 106.73K Avg daily vol (3M) 738.33K

Labcorp Holdings Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Labcorp Holdings Inc. (LH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-10
Labcorp Holdings Inc. (LH) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-28
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Confident tone PAMA reimbursement risk Third-quarter financial performance Biopharma laboratory services
Revenue
$3.81B
▲ 6.9% YoY
Diluted EPS
$3.22
▲ 3.2% YoY
Gross margin
29.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-15
Labcorp Holdings Inc. (LH) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Capital Markets Day
Investor event
2026-09-10
Labcorp Holdings Inc. (LH) September 10, 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-30
Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript
Confident tone Biopharma Laboratory Services (BLS) Specialty Testing / Oncology Expansion PAMA / Regulatory & Legislative Risk
Revenue
$3.73B
▲ 5.8% YoY
Diluted EPS
$3.64
▲ 28.2% YoY
Gross margin
29.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Labcorp Holdings Inc. (LH) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-21
Labcorp Holdings Inc. (LH) May 21, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-30
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
Confident tone Margin expansion and Launchpad productivity Consumer health and digital engagement Specialty testing growth areas
Revenue
$3.54B
▲ 5.8% YoY
Diluted EPS
$3.35
▲ 32.9% YoY
Gross margin
28.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript
Confident tone 2025 Financial Results Specialty/Esoteric Testing Growth Early Development/BLS
Revenue
$3.52B*
▲ 5.6% YoY
Gross margin
28.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
Confident tone Early Development weakness and restructuring Invitae integration Biopharma Laboratory Services (Central Lab)
Revenue
$3.56B
▲ 8.6% YoY
Diluted EPS
$3.12
▲ 56% YoY
Gross margin
28.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
Confident tone Biopharma Laboratory Services (BLS) momentum Diagnostics Laboratories segment growth PAMA reimbursement risk
Revenue
$3.53B
▲ 9.5% YoY
Diluted EPS
$2.84
▲ 16.9% YoY
Gross margin
29.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Confident tone Biopharma Laboratory Services (BLS) 2025 financial guidance Diagnostics Laboratories growth and margin
Revenue
$3.35B
▲ 5.3% YoY
Diluted EPS
$2.52
▼ 6.3% YoY
Gross margin
28.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
Confident tone 2024 financial performance Strategic acquisitions and Invitae integration 2025 guidance and outlook
Revenue
$3.33B*
▲ 9.8% YoY
Gross margin
26.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-24
Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript
Positive tone Acquisitions and Partnerships Diagnostics and Biopharma Growth Book-to-Bill and Early Development
Revenue
$3.28B
▲ 7.4% YoY
Diluted EPS
$2.00
▼ 5.2% YoY
Gross margin
27.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Labcorp Holdings Inc. (LH) Q2 2024 Earnings Call Transcript
Confident tone Invitae acquisition 2024 guidance and margins LaunchPad cost initiative
Revenue
$3.22B
▲ 6.2% YoY
Diluted EPS
$2.43
▲ 14.6% YoY
Gross margin
28.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
Labcorp Holdings Inc. (LH) Q1 2024 Earnings Call Transcript
Confident tone Quarterly Financial Results & Guidance Diagnostics Margin Pressure Early Development Biopharma Weakness
Revenue
$3.18B
▲ 4.6% YoY
Diluted EPS
$2.69
▲ 12.6% YoY
Gross margin
28.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
Labcorp Holdings Inc. (LH) Q4 2023 Earnings Call Transcript
Confident tone Biopharma laboratory services 2024 financial guidance Diagnostics base business growth
Revenue
$3.03B*
▲ 39.5% YoY
Gross margin
27.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-26
Labcorp Holdings Inc. (LH) Q3 2023 Earnings Call Transcript
Revenue
$3.06B
▲ 6.6% YoY
Diluted EPS
$2.11
▼ 45.9% YoY
Gross margin
27.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Labcorp Holdings Inc. (LH) Q2 2023 Earnings Call Transcript
Revenue
$3.03B
▲ 3.8% YoY
Diluted EPS
$2.12
▼ 45.2% YoY
Gross margin
27.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Labcorp Holdings Inc. (LH) Q1 2023 Earnings Call Transcript
Revenue
$3.04B
▼ 22.1% YoY
Diluted EPS
$2.39
▼ 54.3% YoY
Gross margin
28.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Labcorp Holdings Inc. (LH) Q4 2022 Earnings Call Transcript
Revenue
$2.17B*
▲ 103% YoY
Gross margin
29.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Labcorp Holdings Inc. (LH) Q3 2022 Earnings Call Transcript
Revenue
$2.87B
▼ 29.4% YoY
Diluted EPS
$3.90
▼ 35.5% YoY
Gross margin
30.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Labcorp Holdings Inc. (LH) Q2 2022 Earnings Call Transcript
Revenue
$2.92B
▼ 23.9% YoY
Diluted EPS
$3.87
▼ 18.7% YoY
Gross margin
32.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Labcorp Holdings Inc. (LH) Q1 2022 Earnings Call Transcript
Revenue
$3.90B
▼ 6.3% YoY
Diluted EPS
$5.23
▼ 33.1% YoY
Gross margin
31.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Labcorp Holdings Inc. (LH) Q4 2021 Earnings Call Transcript
Revenue
$1.07B*
▼ 76.1% YoY
Gross margin
69.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Labcorp Holdings Inc. (LH) Q3 2021 Earnings Call Transcript
Revenue
$4.06B
▲ 4.3% YoY
Diluted EPS
$6.05
▼ 15.6% YoY
Gross margin
34.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Labcorp Holdings Inc. (LH) Q2 2021 Earnings Call Transcript
Revenue
$3.84B
▲ 38.7% YoY
Diluted EPS
$4.76
▲ 100.8% YoY
Gross margin
32.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Labcorp Holdings Inc. (LH) Q1 2021 Earnings Call Transcript
Revenue
$4.16B
▲ 47.4% YoY
Diluted EPS
$7.82
Gross margin
38.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Labcorp Holdings Inc. (LH) Q4 2020 Earnings Call Transcript
Revenue
$4.49B*
▲ 52% YoY
Gross margin
42.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Labcorp Holdings Inc. (LH) Q3 2020 Earnings Call Transcript
Revenue
$3.90B
▲ 33% YoY
Diluted EPS
$7.17
▲ 218.7% YoY
Gross margin
40.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Labcorp Holdings Inc. (LH) Q2 2020 Earnings Call Transcript
Revenue
$2.77B
▼ 3.9% YoY
Diluted EPS
$2.37
▲ 22.8% YoY
Gross margin
27.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
Labcorp Holdings Inc. (LH) Q1 2020 Earnings Call Transcript
Revenue
$2.82B
▲ 1.2% YoY
Diluted EPS
$-3.27
▼ 275.8% YoY
Gross margin
25.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Labcorp Holdings Inc. (LH) Q4 2019 Earnings Call
Revenue
$2.95B
▲ 6% YoY
Diluted EPS
$2.32
▲ 48.7% YoY
Gross margin
27.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–33 of 33 webcasts
Key facts CIK 920148 CUSIP 504922105 13F (30d) 1020 filings 956 filers Visit website Investor relations